ChromaTan Corp. Start-Up Stadium

4:00 PM–4:15 PM Jun 5, 2019 (US - Eastern)

Hall E, Booth 3971, Level 200


Biotechnology company that has developed and patented Continuous Countercurrent Tangential Chromatography™ to address unmet medical needs through antibody production for use in the manufacturing and purification of therapeutic proteins and vaccines. This new technology allows time-effective and cost-effective responses to pandemic threats due to its continuous processing, scalability, and disposable flow path. It is a column-free, single-use alternative to column chromatography that could significantly reduce operating costs.

Session ID: 545662